Emergent BioSolutions, Inc. (EBS)
8.05
-0.14
(-1.71%)
USD |
NYSE |
Mar 23, 16:00
8.05
0.00 (0.00%)
Pre-Market: 20:00
Emergent BioSolutions Accounts Payable (Quarterly) : 55.60M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.144B |
| Eli Lilly & Co. | 5.379B |
| Penumbra, Inc. | 34.74M |
| Disc Medicine, Inc. | 9.018M |
| MetaVia, Inc. | 2.599M |